WallStreetZenWallStreetZen

NASDAQ: CGON
Cg Oncology Inc Stock

$31.90+0.47 (+1.5%)
Updated Jun 24, 2024
CGON Price
$31.90
Fair Value Price
N/A
Market Cap
$2.13B
52 Week Low
$25.77
52 Week High
$50.23
P/E
N/A
P/B
3.74x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.02
Operating Cash Flow
N/A
Beta
1.19
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CGON Overview

CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CGON scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CGON is good value based on its book value relative to its share price (3.74x), compared to the US Biotechnology industry average (6.29x)
P/B vs Industry Valuation
CGON's short-term assets ($578.61M) exceed its short-term liabilities ($9.98M)
Short-term Liabilities Financials
CGON's short-term assets ($578.61M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more CGON due diligence checks available for Premium users.

Be the first to know about important CGON news, forecast changes, insider trades & much more!

CGON News

Valuation

CGON price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.74x
Industry
6.29x
CGON is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CGON's financial health

Profit margin

Revenue
$529.0k
Net Income
-$16.9M
Profit Margin
-3,200.8%

Assets to liabilities

Assets
$579.1M
Liabilities
$10.2M
Debt to equity
0.02
CGON's short-term assets ($578.61M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CGON's short-term assets ($578.61M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CGON's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$26.0M
Investing
-$307.4M
Financing
$402.7M

CGON vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CGON$2.13B+1.50%N/A3.74x
RCKT$2.18B+7.03%-8.44x4.95x
FTRE$2.06B-0.65%-16.79x1.29x
BEAM$2.04B+8.24%-15.52x2.24x
GPCR$2.03B-4.15%-19.16x4.73x

Cg Oncology Stock FAQ

What is Cg Oncology's quote symbol?

(NASDAQ: CGON) Cg Oncology trades on the NASDAQ under the ticker symbol CGON. Cg Oncology stock quotes can also be displayed as NASDAQ: CGON.

If you're new to stock investing, here's how to buy Cg Oncology stock.

What is the 52 week high and low for Cg Oncology (NASDAQ: CGON)?

(NASDAQ: CGON) Cg Oncology's 52-week high was $50.23, and its 52-week low was $25.77. It is currently -36.49% from its 52-week high and 23.79% from its 52-week low.

How much is Cg Oncology's stock price per share?

(NASDAQ: CGON) Cg Oncology stock price per share is $31.90 today (as of Jun 24, 2024).

What is Cg Oncology's Market Cap?

(NASDAQ: CGON) Cg Oncology's market cap is $2.13B, as of Jun 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cg Oncology's market cap is calculated by multiplying CGON's current stock price of $31.90 by CGON's total outstanding shares of 66,640,150.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.